Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000

David A. Wetter, Mark D P Davis, James A. Yiannias, Janet F. Cheng, Suzanne M. Connolly, Rokea A. El-Azhary, Sara A. Farmer, Debra D. Fett, Janis S. Johnson, Diane L. Nordberg Linehan, Donna M. Richardson, Arnold L. Schroeter

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Background: Patch testing is a diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis. A standard series of allergens similar to that used by the North American Contact Dermatitis Group (NACDG) is used at Mayo Clinic. Objective: Our aim was to report the results of patch testing with a standard series at Mayo Clinic from July 1, 1998, to Dec 31, 2000 and to compare our findings with those of the NACDG during the same period. Methods: The results of patch testing with the standard series at Mayo Clinic were examined. Positive reaction rates were compared between Mayo Clinic and the NACDG. Results: During the 30-month period, 1324 Mayo Clinic patients were patch tested with a standard series of allergens (mean, 60 allergens), whereas the NACDG standard series during this period included 50 allergens. Overall, 917 patients (69.3%) had at least one positive reaction and 606 patients (45.8%) had two or more positive reactions. The 10 allergens used both by Mayo Clinic and by the NACDG that most frequently caused positive reactions were nickel sulfate hexahydrate, balsam of Peru (Myroxylon pereirae), neomycin sulfate, cobalt chloride, fragrance mix, potassium dichromate (0.25%), thimerosal, bacitracin, formaldehyde, and glutaraldehyde. Statistically significant differences in positive reaction rates (P < .05) were observed for 12 of the 43 allergens common to both Mayo Clinic and the NACDG. Conclusion: With large standard patch test series, one can identify commonly encountered and potentially relevant contact allergens.

Original languageEnglish (US)
Pages (from-to)416-421
Number of pages6
JournalJournal of the American Academy of Dermatology
Volume53
Issue number3
DOIs
StatePublished - Sep 2005

Fingerprint

Patch Tests
Contact Dermatitis
Allergens
Myroxylon
Potassium Dichromate
Thimerosal
Bacitracin
Allergic Contact Dermatitis
Neomycin
Glutaral
Formaldehyde

ASJC Scopus subject areas

  • Dermatology

Cite this

Wetter, D. A., Davis, M. D. P., Yiannias, J. A., Cheng, J. F., Connolly, S. M., El-Azhary, R. A., ... Schroeter, A. L. (2005). Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000. Journal of the American Academy of Dermatology, 53(3), 416-421. https://doi.org/10.1016/j.jaad.2005.04.077

Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000. / Wetter, David A.; Davis, Mark D P; Yiannias, James A.; Cheng, Janet F.; Connolly, Suzanne M.; El-Azhary, Rokea A.; Farmer, Sara A.; Fett, Debra D.; Johnson, Janis S.; Nordberg Linehan, Diane L.; Richardson, Donna M.; Schroeter, Arnold L.

In: Journal of the American Academy of Dermatology, Vol. 53, No. 3, 09.2005, p. 416-421.

Research output: Contribution to journalArticle

Wetter, DA, Davis, MDP, Yiannias, JA, Cheng, JF, Connolly, SM, El-Azhary, RA, Farmer, SA, Fett, DD, Johnson, JS, Nordberg Linehan, DL, Richardson, DM & Schroeter, AL 2005, 'Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000', Journal of the American Academy of Dermatology, vol. 53, no. 3, pp. 416-421. https://doi.org/10.1016/j.jaad.2005.04.077
Wetter, David A. ; Davis, Mark D P ; Yiannias, James A. ; Cheng, Janet F. ; Connolly, Suzanne M. ; El-Azhary, Rokea A. ; Farmer, Sara A. ; Fett, Debra D. ; Johnson, Janis S. ; Nordberg Linehan, Diane L. ; Richardson, Donna M. ; Schroeter, Arnold L. / Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000. In: Journal of the American Academy of Dermatology. 2005 ; Vol. 53, No. 3. pp. 416-421.
@article{8c994c6bb83a43c9a59bc20cb1b29533,
title = "Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000",
abstract = "Background: Patch testing is a diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis. A standard series of allergens similar to that used by the North American Contact Dermatitis Group (NACDG) is used at Mayo Clinic. Objective: Our aim was to report the results of patch testing with a standard series at Mayo Clinic from July 1, 1998, to Dec 31, 2000 and to compare our findings with those of the NACDG during the same period. Methods: The results of patch testing with the standard series at Mayo Clinic were examined. Positive reaction rates were compared between Mayo Clinic and the NACDG. Results: During the 30-month period, 1324 Mayo Clinic patients were patch tested with a standard series of allergens (mean, 60 allergens), whereas the NACDG standard series during this period included 50 allergens. Overall, 917 patients (69.3{\%}) had at least one positive reaction and 606 patients (45.8{\%}) had two or more positive reactions. The 10 allergens used both by Mayo Clinic and by the NACDG that most frequently caused positive reactions were nickel sulfate hexahydrate, balsam of Peru (Myroxylon pereirae), neomycin sulfate, cobalt chloride, fragrance mix, potassium dichromate (0.25{\%}), thimerosal, bacitracin, formaldehyde, and glutaraldehyde. Statistically significant differences in positive reaction rates (P < .05) were observed for 12 of the 43 allergens common to both Mayo Clinic and the NACDG. Conclusion: With large standard patch test series, one can identify commonly encountered and potentially relevant contact allergens.",
author = "Wetter, {David A.} and Davis, {Mark D P} and Yiannias, {James A.} and Cheng, {Janet F.} and Connolly, {Suzanne M.} and El-Azhary, {Rokea A.} and Farmer, {Sara A.} and Fett, {Debra D.} and Johnson, {Janis S.} and {Nordberg Linehan}, {Diane L.} and Richardson, {Donna M.} and Schroeter, {Arnold L.}",
year = "2005",
month = "9",
doi = "10.1016/j.jaad.2005.04.077",
language = "English (US)",
volume = "53",
pages = "416--421",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000

AU - Wetter, David A.

AU - Davis, Mark D P

AU - Yiannias, James A.

AU - Cheng, Janet F.

AU - Connolly, Suzanne M.

AU - El-Azhary, Rokea A.

AU - Farmer, Sara A.

AU - Fett, Debra D.

AU - Johnson, Janis S.

AU - Nordberg Linehan, Diane L.

AU - Richardson, Donna M.

AU - Schroeter, Arnold L.

PY - 2005/9

Y1 - 2005/9

N2 - Background: Patch testing is a diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis. A standard series of allergens similar to that used by the North American Contact Dermatitis Group (NACDG) is used at Mayo Clinic. Objective: Our aim was to report the results of patch testing with a standard series at Mayo Clinic from July 1, 1998, to Dec 31, 2000 and to compare our findings with those of the NACDG during the same period. Methods: The results of patch testing with the standard series at Mayo Clinic were examined. Positive reaction rates were compared between Mayo Clinic and the NACDG. Results: During the 30-month period, 1324 Mayo Clinic patients were patch tested with a standard series of allergens (mean, 60 allergens), whereas the NACDG standard series during this period included 50 allergens. Overall, 917 patients (69.3%) had at least one positive reaction and 606 patients (45.8%) had two or more positive reactions. The 10 allergens used both by Mayo Clinic and by the NACDG that most frequently caused positive reactions were nickel sulfate hexahydrate, balsam of Peru (Myroxylon pereirae), neomycin sulfate, cobalt chloride, fragrance mix, potassium dichromate (0.25%), thimerosal, bacitracin, formaldehyde, and glutaraldehyde. Statistically significant differences in positive reaction rates (P < .05) were observed for 12 of the 43 allergens common to both Mayo Clinic and the NACDG. Conclusion: With large standard patch test series, one can identify commonly encountered and potentially relevant contact allergens.

AB - Background: Patch testing is a diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis. A standard series of allergens similar to that used by the North American Contact Dermatitis Group (NACDG) is used at Mayo Clinic. Objective: Our aim was to report the results of patch testing with a standard series at Mayo Clinic from July 1, 1998, to Dec 31, 2000 and to compare our findings with those of the NACDG during the same period. Methods: The results of patch testing with the standard series at Mayo Clinic were examined. Positive reaction rates were compared between Mayo Clinic and the NACDG. Results: During the 30-month period, 1324 Mayo Clinic patients were patch tested with a standard series of allergens (mean, 60 allergens), whereas the NACDG standard series during this period included 50 allergens. Overall, 917 patients (69.3%) had at least one positive reaction and 606 patients (45.8%) had two or more positive reactions. The 10 allergens used both by Mayo Clinic and by the NACDG that most frequently caused positive reactions were nickel sulfate hexahydrate, balsam of Peru (Myroxylon pereirae), neomycin sulfate, cobalt chloride, fragrance mix, potassium dichromate (0.25%), thimerosal, bacitracin, formaldehyde, and glutaraldehyde. Statistically significant differences in positive reaction rates (P < .05) were observed for 12 of the 43 allergens common to both Mayo Clinic and the NACDG. Conclusion: With large standard patch test series, one can identify commonly encountered and potentially relevant contact allergens.

UR - http://www.scopus.com/inward/record.url?scp=23944515558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944515558&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2005.04.077

DO - 10.1016/j.jaad.2005.04.077

M3 - Article

VL - 53

SP - 416

EP - 421

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -